Next Quarterly Earnings
Friday, October 30, 2026
CW 44
Pre-Market
In 64 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
AstraZeneca
AstraZeneca is a leading, research-based biopharmaceutical company headquartered in Great Britain. The company is dedicated to the development and commercialization of innovative therapies for serious diseases. Key areas of focus include oncology, cardiovascular, renal & metabolism, and respiratory & immunology, aiming to improve patient lives globally.
Recap: the latest results
AstraZeneca (AZN) reported its Q2 2026 financial results on July 27, 2026, before the market open. The company reported earnings per share (EPS) of 1.99 GBP, beating the analyst estimate of 1.87 GBP by 6.2%. Revenue for the quarter reached 11636 million GBP. Following the publication, the stock price rose by 1.72%.
Generated automatically from our data — as of 08/06/2026 Read the article →
Frequently asked questions
When will AstraZeneca report its next quarterly earnings?
AstraZeneca is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did AstraZeneca last report quarterly earnings?
AstraZeneca last reported quarterly earnings on 7/27/2026 (Q2 2026). Earnings per share (EPS) came in at 1.99 GBP.
How does AstraZeneca stock react to earnings?
Across its last 5 earnings reports, AstraZeneca stock moved by ±2.8% on average the following day. The largest reaction was +5.9% on 02/06/2025; 4 of 5 reactions were positive.
How often has AstraZeneca beaten expectations?
AstraZeneca has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
How do I add the AstraZeneca earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±2.8%
Avg. next-day move
+5.9%
Largest move (02/06/2025)
80%
Share of positive reactions
±7.9%
Avg. move after 7 days
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
5/5
Quarters above estimates
100%
Beat rate
+2%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
AstraZeneca
Country
🇬🇧
More Financial Information